Analysts Have Reduced Target Prices for Mylan in March
How Generic Pharmaceutical Stocks Are Positioned this Month(Continued from Prior Part)Analysts’ recommendations and target prices Wall Street analysts expect an upside potential of 26.56% for Mylan (MYL), based on the company’s closing price on